Updated:
WFD Ventures
WFD Ventures LLC offers equity financing and industry expertise to medical device and healthcare technology companies. The firm's principals have developed and...
WFD Ventures
WFD Ventures LLC offers equity financing and industry expertise to medical device and healthcare technology companies. The firm's principals have developed and commercialized dozens of technologies. They seek partnerships with entrepreneurs, doctors, and scientists to improve medical outcomes and maximize financial potential.
General information
Firm type
Venture Capital
Year founded
2002
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Yumin Choi
Managing Partner
Sector focus
Frequently asked questions
Who leads investment decisions at WFD Ventures?
Managing Partner Yumin Choi leads the investment function at WFD Ventures. He has been with the firm since its founding and is the primary decision-maker on new commitments, supported by a compact investment team. The firm has not publicly named additional general partners.
What investment stages does WFD Ventures target?
WFD Ventures focuses on early-stage medical technology, typically entering at Seed through Series B. The firm writes initial checks that are generally below $10 million and reserves capital for follow-on rounds through commercialization. The firm has backed companies from pre-revenue IDE trial stage through post-approval scaling.
Does WFD Ventures co-invest alongside strategic corporate investors?
Yes. WFD Ventures frequently participates in syndicates that include large medical device strategics such as Medtronic, Boston Scientific, and Johnson & Johnson Development Corporation. Its domain-expert posture makes it a credible partner for corporate venture arms seeking clinical-stage validation before committing their own balance sheets.
What is WFD Ventures' relationship with TransMedics?
WFD Ventures was an early backer of TransMedics, the organ preservation and transport platform, investing at the Series A stage. TransMedics went public in 2019 and reported its first full year of GAAP profitability in March 2024, marking a significant return milestone for the firm's medtech-focused strategy.
How is WFD Ventures structured — is it a family office or a venture firm?
WFD Ventures operates as a venture capital firm, not a family office, raising committed capital from external limited partners across multiple fund vintages. Its most recent vehicle, WFD Ventures VI, was disclosed in SEC filings in 2022. The firm does not publicly identify its limited partners.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: